Fresenius SE & Co KGaA ADR (FSNUY)

OTC Markets
Currency in USD
11.390
-0.040(-0.35%)
Closed·
FSNUY Scorecard
Full Analysis
High shareholder yield
Earnings results expected in 9 days
Fair Value
Day's Range
11.36011.430
52 wk Range
7.31011.555
Key Statistics
Edit
Prev. Close
11.39
Open
11.42
Day's Range
11.36-11.43
52 wk Range
7.31-11.555
Volume
19.47K
Average Volume (3m)
56.04K
1-Year Change
55.22%
Book Value / Share
35.94
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
FSNUY Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
12.400
Upside
+8.87%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low P/E ratio relative to near-term earnings growth
Show more

Fresenius SE & Co KGaA ADR Company Profile

Fresenius SE & Co. KGaA, a health care company, provides products and services for chronically ill patients. It operates through Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed segments. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure. This segment provides dialyzers, dialysis machines, and related disposable products, as well as dialysis-related services. The Fresenius Kabi segment engages in the therapy and care of critically and chronically ill patients; enteral and parenteral nutrition products; medical technologies, as well as disposables, infusions pumps, apheresis machines, cell therapy devices, and other products. The Fresenius Helios segment provides clinical and nursing care facilities. The Fresenius Vamed segment provides services for hospitals and other healthcare facilities. This segment also offers operational management of healthcare facilities and provides services to patients. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is based in Bad Homburg vor der Höhe, Germany.

Compare FSNUY to Peers and Sector

Metrics to compare
FSNUY
Peers
Sector
Relationship
P/E Ratio
21.5x17.6x−0.5x
PEG Ratio
0.120.080.00
Price/Book
1.1x1.8x2.6x
Price / LTM Sales
1.0x0.8x2.9x
Upside (Analyst Target)
8.9%63.8%57.1%
Fair Value Upside
Unlock27.3%9.0%Unlock

Analyst Ratings

2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 12.400
(+8.87% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 1.85%
Dividend Yield
1.60%
Industry Median 1.55%
Annualised payout
0.18
Paid unevenly
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Feb 25, 2025
EPS / Forecast
0.1967 / 0.173
Revenue / Forecast
5.81B / 5.79B
EPS Revisions
Last 90 days

People Also Watch

26.48
SARO
+0.84%
166.23
MTUAY
+4.73%
2.240
DCGO
+0.90%

FAQ

What Is the Fresenius ADR (FSNUY) Stock Price Today?

The Fresenius ADR stock price today is 11.39

What Stock Exchange Does Fresenius ADR Trade On?

Fresenius ADR is listed and trades on the OTC Markets stock exchange.

What Is the Stock Symbol for Fresenius ADR?

The stock symbol for Fresenius ADR is "FSNUY."

Does Fresenius ADR Pay Dividends? What’s The Current Dividend Yield?

The Fresenius ADR dividend yield is 1.6%.

What Is the Fresenius ADR Market Cap?

As of today, Fresenius ADR market cap is 25.87B.

What is Fresenius ADR Earnings Per Share?

The Fresenius ADR EPS is 1.85.

What Is the Next Fresenius ADR Earnings Date?

Fresenius ADR will release its next earnings report on 06 May 2025.

From a Technical Analysis Perspective, Is FSNUY a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.